Investing in world class biotech companies to make the “impossible” possible. Codon Capital is a San Francisco-based biotech venture capital company, specializing in therapeutics and synthetic biology. Our investment approach is to fund startup teams that can execute on difficult technical, definable achievements that enable breakthrough biotech products. We’re investing in solutions to the most critical problems of human health and sustainability, and in teams who can make the impossible possible. Our early stage investments back teams to build enduring quality solutions, which sometimes are snapped up via acquisitions, but also have the option to raise additional equity at attractive valuations to seek even more value.